480 Biomedical's self-expanding scaffold technology platform employs a unique composite design that strikes an optimal balance of strength, flexibility and bioresorption.
Our lead product is the proprietary Stanza™ bioresorbable, drug eluting, scaffold and delivery system for use in treating peripheral artery disease in the superficial femoral artery, a condition that is poorly addressed today.
June 18, 2015
June 1, 2015
480 Biomedical Awarded $1 Million Phase II NHLBI Contract to Advance Bioresorbable Scaffold for Pediatric Pulmonary Artery Stenosis
July 9, 2014
BSI Certificate Awarded
December 11, 2013
Products presented in this website are not available for sale or distribution and are limited to clinical investigational use only.